Skip to main content
U.S. flag
Health and Human Services Logo

An official website of the Department of Health & Human Services

menu-iconMore mobile-close-icon
mobile-back-btn-icon Back
  • menu-iconMenu
  • mobile-search-icon
AHRQ: Agency for Healthcare Research and Quality
  • Search All AHRQ Sites
  • Careers
  • Contact Us
  • Español
  • FAQs
  • Email Updates
MEPS Home Medical Expenditure Panel Survey
Font Size:
Contact MEPS FAQ Site Map  
S
M
L
XL
 
 
Prescribed Drug Estimates: 2000
Table 1.1 Top Prescribed Drugs by Total Expenditures, 2000

Prescribed
drug name

Total expenditures
ranking

Total
expenditures
Total number of
persons with expenditures

Lipitor
1
3,321,081,920
7,099,278
Prilosec
2
2,411,152,120
5,499,922
Zocor
3
2,175,864,735
4,843,405
Prozac
4
1,959,836,264
3,390,932
Claritin
5
1,838,573,218
10,156,143
Glucophage
6
1,775,788,416
4,523,173
Zyprexa
7
1,744,552,268
813,415
Celebrex
8
1,729,050,405
6,145,784
Premarin
9
1,582,417,298
9,001,244

Prevacid

10
1,552,442,022
3,919,200

 

Standard Errors for Table 1.1: Top Prescribed Drugs by Total Expenditures, 2000
Prescribed
drug name
Total
expenditures
Total number of
persons with expenditures

Lipitor
226,185,831.00
385,370.21
Prilosec
199,873,894.98
360,160.19
Zocor
207,069,213.99
414,517.77
Prozac
260,949,704.64
348,050.23
Claritin
135,121,801.86
539,589.54
Glucophage
144,381,343.12
345,621.29
Zyprexa
553,707,276.52
141,735.34
Celebrex
127,041,655.13
398,171.08
Premarin
158,374,433.53
646,631.26
Prevacid
163,387,134.80
340,816.51

 

MEPS HOME . CONTACT MEPS . MEPS FAQ . MEPS SITE MAP . MEPS PRIVACY POLICY . ACCESSIBILITY . VIEWERS & PLAYERS . COPYRIGHT
Back to topGo back to top
Back to Top Go back to top

Connect With Us

Facebook Twitter You Tube LinkedIn

Sign up for Email Updates

To sign up for updates or to access your subscriber preferences, please enter your email address below.

Agency for Healthcare Research and Quality

5600 Fishers Lane
Rockville, MD 20857
Telephone: (301) 427-1364

  • Careers
  • Contact Us
  • Español
  • FAQs
  • Accessibility
  • Disclaimers
  • EEO
  • Electronic Policies
  • FOIA
  • HHS Digital Strategy
  • HHS Nondiscrimination Notice
  • Inspector General
  • Plain Writing Act
  • Privacy Policy
  • Viewers & Players
  • U.S. Department of Health & Human Services
  • The White House
  • USA.gov